Archives

Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-09-19
    E.g., 2018-09-19

Archive Search

1 results
4:53 PM, May 03, 2013  |  BC Extra | Top Story

Regeneron gains after 1Q13 results

targeting platelet derived growth factor (PDGF) for all indications including ophthalmology, and to antibodies targeting angiopoietin 2
ANG2 ; ANGPT2 ) for ophthalmology indications only. Sanofi will receive $10 million up front …
40 million in milestones for the PDGF antibodies and a $5 million milestone for the ANG2